2019

1. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

   Journal of Clinical Medicine, Vol. 8, Núm. 8

2. The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma

   Cancers, Vol. 11, Núm. 11